|

CD371-specific/YSNVz/I-18 CAR T cells Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Memorial Sloan Kettering Cancer Center1

Indications

  • Relapsed Acute Myeloid Leukemia1
  • Acute Myeloid Leukemia, in Relapse1
  • Refractory Acute Myeloid Leukemia1
  • Acute Myeloid Leukemia Refractory1
  • Acute Myeloid Leukemia1

Basking Ridge, New Jersey1 trial

A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia

Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.